Home › NDC Lookup › RxCUI directory › RxCUI 200801

Furosemide 20 MG Oral Tablet [Lasix] — RxCUI 200801

RxNorm drug concept · Semantic branded drug
RxCUI 200801 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 7 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI200801
Official nameFurosemide 20 MG Oral Tablet [Lasix]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asLasix 20 MG Oral Tablet
FDA products mapped3
Package NDCs mapped7
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Furosemide Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Injectable furosemide is used when you need faster action than a pill can provide, or when you can't take oral medication — for example, in an emergency like acute pulmonary edema...
  • Why am I getting this as an injection instead of a pill?
  • The biggest things to watch for are signs of dehydration — feeling very dizzy, lightheaded, or faint, especially when you stand up — and muscle cramps or weakness, which can signal...
  • What should I watch out for while using furosemide injection?
📖 Read our full Furosemide Injection guide →

🕸️ Concept Web — How Furosemide 20 MG Oral Tablet [Lasix] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Furosemide 20 MG Oral Tablet [Lasix] RxCUI 200801

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Furosemide 4603
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Lasix 202991
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Furosemide Oral Tablet 372281
    • Furosemide Oral Product 1162714
    • Furosemide Pill 1162715
    • Furosemide Oral Tablet [Lasix] 368487
    • Lasix Oral Product 1175647
    • Lasix Pill 1175648
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Furosemide 20 MG Oral Tablet SCD · 310429
  • Furosemide 20 MG SCDC · 315970
  • Furosemide Oral Tablet SCDF · 372281
  • Furosemide Oral Product SCDG · 1162714
  • Furosemide Pill SCDG · 1162715

Brand-Name Concepts

  • Furosemide 20 MG [Lasix] SBDC · 565450
  • Furosemide Oral Tablet [Lasix] SBDF · 368487
  • Lasix Oral Product SBDG · 1175647
  • Lasix Pill SBDG · 1175648
  • Lasix BN · 202991

📦 FDA Products & Package NDCs

3 products · 7 package NDCs
7 package NDCs map to RxCUI 200801 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
30698-0060-01 100 TABLET in 1 BOTTLE (30698-060-01) Lasix Validus Pharmaceuticals LLC 1978-04-24
30698-0060-10 1000 TABLET in 1 BOTTLE (30698-060-10) Lasix Validus Pharmaceuticals LLC 1978-04-24
30698-0060-50 500 TABLET in 1 BOTTLE (30698-060-50) Lasix Validus Pharmaceuticals LLC 1978-04-24
30698-0066-05 50 TABLET in 1 BOTTLE (30698-066-05) Lasix Validus Pharmaceuticals LLC 1978-04-24
30698-0066-50 500 TABLET in 1 BOTTLE (30698-066-50) Lasix Validus Pharmaceuticals LLC 1978-04-24
30698-0067-01 100 TABLET in 1 BOTTLE (30698-067-01) Lasix Validus Pharmaceuticals LLC 1978-04-24
30698-0067-10 1000 TABLET in 1 BOTTLE (30698-067-10) Lasix Validus Pharmaceuticals LLC 1978-04-24
Observed labelers: Validus Pharmaceuticals LLC (7) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.